Replimune Group Payables and Accrued Expenses (Quarterly) Trends

Replimune Group, Inc. (REPL)

8.07 +1.03 (+14.63%) USD | NASDAQ | Mar 06, 16:00

9.21 +1.14 (+14.13%) After-Hours: 20:00

View Payables and Accrued Expenses (Quarterly) for REPL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Payables and Accrued Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Payables and Accrued Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Payables and Accrued Expenses (Quarterly) Benchmarks

Start Trial

Catalyst Pharmaceuticals, Inc.	Upgrade
Sarepta Therapeutics, Inc.	Upgrade
REGENXBIO, Inc.	Upgrade
Bristol Myers Squibb Co.	Upgrade
Mirum Pharmaceuticals, Inc.	Upgrade